pharmaceutical investing Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan
pharmaceutical investing EyeGate Pharmaceuticals Reports Full-Year 2017 Financial Results and Provides Business Update
Premier American Uranium Reports Results Following Annual General and Special Meeting of Shareholders
Nuvau Winter Drilling at Thundermine Returns 5.28 g/t Au over 6.1 m, Including 7.22 g/t Au over 3.1 m
